All relevant data are within the paper.

Introduction {#sec005}
============

Several studies have demonstrated short-term outcomes advantages for the minimally invasive surgery (MIS) approach when compared to open colorectal surgery.\[[@pone.0206277.ref001]--[@pone.0206277.ref008]\] Even with these advantages, only 50--60% of colectomies and 10--20% of rectal resections are completed with a MIS approach.\[[@pone.0206277.ref009]--[@pone.0206277.ref013]\]

When considering MIS options, there may be clinical outcomes advantages to the intracorporeal approach when compared to the extracorporeal technique.\[[@pone.0206277.ref014]--[@pone.0206277.ref017]\] For MIS right colectomy, the extracorporeal anastomosis is typically performed after delivering the specimen through a midline incision extraction site that may result in traction injury to the ileum and colon, and an increased rate of extraction site hernia.\[[@pone.0206277.ref016], [@pone.0206277.ref018]--[@pone.0206277.ref020]\] In contrast, the intracorporeal anastomosis technique is conducted after the specimen is completely detached from surrounding structures and allows the specimen to be removed from extraction site incisions less prone to incisional hernia.\[[@pone.0206277.ref015]--[@pone.0206277.ref017], [@pone.0206277.ref021]--[@pone.0206277.ref025]\]

The purpose of this multi-institutional retrospective study was to compare the short-term clinical outcomes of right colectomy MIS (laparoscopic or robotic-assisted) performed with intracorporeal versus extracorporeal anastomosis for benign and malignant disease.

Methods {#sec006}
=======

Data source {#sec007}
-----------

This study is multi-institutional and retrospective. De-identified peri-operative information for consecutive MIS cases were collected from existing medical records of patients who underwent laparoscopic and robotic-assisted right colectomies for benign and malignant disease at 11 participating institutions in the United States between January 11, 2010, and July 21, 2016. The study was conducted in accordance with institutional review board guidelines at each institution. Data were retrieved using standardized data collection forms to ensure uniformity across participating sites. Operative approach data for colorectal operations included identification of type of anastomosis and converted cases through detailed surveillance of the operative report dictated by the surgeon. Study-specific informed consent waivers for retrospective data collection and Institutional Review Board approval were obtained from each participating clinical site. Clinical site Institutional Review Boards (IRB) included Saint Joseph Mercy Health System IRB, ARIA Health IRB, Western IRB, Honor Health IRB, Florida Hospital IRB, University of California, Irvine, IRB, Orlando Regional Medical Center IRB.

All study patient information was kept confidential and managed in compliance with Health Insurance Portability and Accountability Act of 1996 requirements. The study chairs (RKC and AP) recruited surgeons based on reputation for operative approaches and attendance at national meetings. Surgeons at participating sites were reviewed for eligibility per study protocol and had performed a minimum of 50 laparoscopic and/or robotic-assisted right colectomy cases prior to contributing to a study arm. Most surgeons contributed MIS cases to both the intra- and extracorporeal study arm based on their current practice for the treatment of benign and malignant right colon disease. One surgeon contributed MIS cases to the extracorporeal and not the intracorporeal study arm.

Study cohort {#sec008}
------------

Eligible patients were ≥ 18 years of age and underwent an elective MIS (robotic-assisted or laparoscopic) right colectomy with intracorporeal or extracorporeal anastomosis either at or proximal to the mid-transverse colon for benign or malignant neoplasia, or inflammatory bowel disease. Exclusion criteria were perforated, obstructing, or locally invasive neoplasms; emergency procedures; patients undergoing right colectomy as a secondary procedure; patients receiving neoadjuvant or postoperative radiation therapy for malignant neoplasia.

For the comparison of intra-and extracorporeal anastomosis techniques, baseline patient characteristics as well as postoperative short term clinical and pathologic outcomes were obtained from hospital medical records.

Surgical technique {#sec009}
------------------

Eligible patients underwent elective right colectomy commensurate with the dissection technique of the individual surgeon up to the mid transverse colon for benign or malignant neoplasia and inflammatory bowel disease using a robotic-assisted approach with intracorporeal or extracorporeal anastomosis, or using a laparoscopic approach with intracorporeal or extracorporeal anastomosis.

### Extracorporeal anastomosis technique {#sec010}

Pneumoperitoneum, port placement, and robot docking (for the robotic-assisted group) were achieved after induction of general anesthesia by the operating surgeon method of choice. Medial to lateral and/or lateral to medial dissection was performed and the ileocolic vessels were identified. The extent of intracorporeal or extracorporeal vessel ligation and division, and the degree of intracorporeal or extracorporeal mesenteric dissection were determined by surgeon preference. The gastrocolic ligament was taken down and the hepatic flexure was mobilized. After mobilization of the right colon, a midline port incision---typically the camera port incision---was extended to serve as the extraction site. The specimen was delivered through the midline extraction incision and the anastomosis conducted using standard open techniques. The use of wound protectors and closure methods were per surgeon preference.

### Intracorporeal anastomosis technique {#sec011}

Pneumoperitoneum, port placement, and robot docking (for the robotic-assisted group) were performed after the induction of general anesthesia per surgeon preference. The entire operation including the anastomosis was done by intracorporeal techniques. Medial-to-lateral and lateral-to-medial dissection, ligation and division of the ileocolic, right colic, and middle colic branches were all systematically performed. The right mesocolon was taken down from point of transection of the ileocolic vessels to the terminal ileum and to a pre-determined point on the transverse colon. The transverse colon and ileum were then divided with a robotic-assisted or laparoscopic stapler. The terminal ileum was aligned with the transverse colon in either an isoperistaltic or antiperistaltic configuration with attention turned to constructing the anastomosis. A colotomy and enterotomy were created to form a common enterotomy channel. After performing a stapled anastomosis, the common enterotomy was closed with suturing or stapling techniques. The specimen was extracted through an off-midline (muscle splitting transverse) or Pfannenstiel incision. The use of wound protectors and closure methods were per surgeon preference.

All robotic-assisted right colectomies were performed with either the *da Vinci Si* or *da Vinci Xi* Surgical System (Intuitive Surgical, Inc.). For both intracorporeal and extracorporeal techniques, no attempt was made to control for utilization of the da Vinci Si or da Vinci Xi robotic-assisted systems, or for total mesocolic excision with central vascular ligation.

Outcome and explanatory variables {#sec012}
---------------------------------

Baseline data collected for the statistical model included patient demographics (age, gender), general health factors (BMI, American Society of Anesthesiologists (ASA) Class, functional health status), patient comorbidities (hypertension, diabetes mellitus, cardiopulmonary disorders, vascular disorders, bleeding disorders, gastrointestinal disorders, genitourinary disorders), previous abdominal surgery, preoperative diagnosis (malignant neoplasia, benign neoplasia, inflammatory bowel disease), and pathologic characteristics (tumor size, tumor stage, tumor location).

The outcomes retrieved for comparison of intra- and extracorporeal anastomosis technique study groups included intraoperative data (operative time, conversion to open laparotomy, estimated blood loss), recovery outcomes (days to first bowel movement, hospital length of stay, need for transfusions), total intraoperative procedure-related complications (bleeding requiring additional intervention, visceral injury: bladder, spleen, gastric, small bowel, vascular injury requiring additional intervention), complications related to anesthesia, anastomotic complications), and total postoperative procedure-related complications (surgical site infections (SSI), other wound complications, gastrointestinal complications, postoperative bleeding with or without transfusion, deep venous thrombosis (DVT), genitourinary complications, cardiac complications, pulmonary complications, renal failure) diagnosed both during the index hospitalization prior to discharge as well as after discharge up to 30 days.

Statistical analysis {#sec013}
--------------------

All patient characteristics and study outcomes were summarized in terms of rates, means, standard deviations, and percentages as appropriate. Comparisons for categorical variables were made using a Pearson Chi-squared test or Fisher's exact test as appropriate. Continuous variables were compared using a Student's t-test or an independent samples t-test with Satterthwaite approximation. All analyses were based on available data. No missing data imputation was performed.

Because subjects were not randomly assigned to treatment arms, propensity score matching (PSM) was applied to obtain an approximate unbiased measure of outcomes by balancing important demographics and preoperative characteristics. Matching was performed using a multivariable logistic model to determine the probability of undergoing MIS with an intracorporeal anastomosis. A quintile stratification matching algorithm was applied. The covariates include BMI, ASA Class, comorbidities (hypertension, diabetes mellitus, cardiopulmonary disorders, vascular disorders, bleeding disorders, gastrointestinal disorders, genitourinary disorders), preoperative diagnosis, and previous abdominal surgery (exploratory/diagnostic procedures). Each Propensity Score Model was evaluated according to Faries *et al*., (2010)\[[@pone.0206277.ref026]\] to ensure best propensity score distribution and best overall PSM fit. The adjusted analysis of all binary and continuous outcomes was carried out using a regression model stratified on propensity score quintile. In case of binary outcome, logistic regression was employed. Ordinary outcomes were evaluated with van Elteren test for stratified ordinary data. Statistical significance was defined as p\<0.05.

All analyses were carried out using SAS 9.4 software for Windows (SAS Institute, Inc., Cary, NC, USA).

Results and discussion {#sec014}
======================

[Fig 1](#pone.0206277.g001){ref-type="fig"} demonstrates the total number of study patients and the number of patients in each study group before and after propensity score adjustment. Recruiting surgeons for the laparoscopic right colectomy intracorporeal (LRCIA) group was challenging because of the small number of surgeons using this technique. The number of patients in the LRCIA study arm was therefore considerably smaller than the other study arms. Propensity scores were not assigned to 6 patients because of unknown baseline medical history covariates (comorbidities and previous abdominal surgery)---one patient in the robotic right colectomy intracorporeal (RRCIA) group and 5 patients in the laparoscopic right colectomy extracorporeal (LRCEA) group. Patient demographics and preoperative characteristics were statistically similar across both groups regarding age, gender, BMI, ASA group, previous abdominal surgery, preoperative diagnosis and comorbidity ([Table 1](#pone.0206277.t001){ref-type="table"}).

![Patient distribution in treatment arms.](pone.0206277.g001){#pone.0206277.g001}

10.1371/journal.pone.0206277.t001

###### Patient demographics and preoperative characteristics of intracorporeal and extracorporeal groups.

![](pone.0206277.t001){#pone.0206277.t001g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                                        IA\                   EA\                   Unadjusted\                                     Adjusted\
                                                   n = 379\              n = 650\              p-value[^a^](#t001fn005){ref-type="table-fn"}   p-value[^b^](#t001fn006){ref-type="table-fn"}
                                                   (RRCIA n = 335\       (RRCEA n = 253\                                                       
                                                   LRCIA n = 44)         LRCEA n = 397)                                                        
  ------------------------------------------------ --------------------- --------------------- ----------------------------------------------- -----------------------------------------------
  Age (years)                                                                                                                                  

  Mean ± SD \[n\]                                  66.2 ± 12.1\          65.9 ± 13.3 \[650\]   0.71                                            0.83
                                                   \[379\]                                                                                     

  Gender, n (%)                                                                                                                                

  Female                                           199 (52.5%)           316 (48.6%)           0.23                                            0.16

  Male                                             180 (47.5%)           334 (51.4%)                                                           

  BMI                                                                                                                                          

  Mean ± SD \[n\]\                                 29.6 ± 6.5 \[379\]\   28.2 ± 6.1 \[650\]\   0.001                                           0.84
  (95% CI)                                         (28.9, 30.2)          (27.8, 28.7)                                                          

  ASA group                                                                                                                                    

  ASA class 1--2                                   167 (44.1%)           380 (58.5%)           \<0.0001                                        0.62

  ASA class 3--6                                   208 (54.9%)           258 (39.7%)                                                           

  Unknown[\*\*](#t001fn004){ref-type="table-fn"}   4 (1.1%)              12 (1.8%)                                                             

  Previous Abdominal Surgery, n (%)                196 (51.7%)           309 (47.5%)           0.34                                            0.33

  Preoperative Diagnosis, n (%)                                                                                                                

  Benign Neoplasm                                  180 (47.5%)           302 (46.5%)           0.75                                            0.84

  Malignant Neoplasm                               178 (47.0%)           298 (45.8%)           0.73                                            0.82

  Inflammatory Bowel Disease                       18 (4.7%)             43 (6.6%)             0.22                                            0.96

  ≥ 1 Comorbidity, n (%)                           288 (76.0%)           468 (72.0%)           0.16                                            0.99
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

IA = Intracorporeal, EA = Extracorporeal, SD = standard deviation, min = minutes, n = number

RRCIA = Robotic Right Colectomy Intracorporeal Anastomosis, LRCIA = Laparoscopic Right Colectomy Intracorporeal Anastomosis

RRCEA = Robotic Right Colectomy Extracorporeal Anastomosis, LRCEA = Laparoscopic Right Colectomy Extracorporeal Anastomosis

\*\* = unknown or missing data

^a^p value before propensity score adjustment

^b^p value after propensity score adjustment

There were no statistically significant differences in the post-operative pathological outcomes between the intracorporeal and extracorporeal anastomosis groups. One hundred eighty-seven (49.3%) in the IA group and 307 (47.2%) in the EA group had malignant neoplasia (p = 0.99). The mean tumor size was similar in the IA and EA groups (mean ±SD: 4.1 ±2.1 cm and 4.3 ±2.5 cm respectively (p = 0.45). There was no significant difference in pathologic tumor stage (p = 0.57), and tumor location defined as cecum, ascending colon, hepatic flexure, and up to mid transverse colon (p = 0.68) between the two groups ([Table 2](#pone.0206277.t002){ref-type="table"}).

10.1371/journal.pone.0206277.t002

###### Postoperative pathology.

![](pone.0206277.t002){#pone.0206277.t002g}

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Postoperative Pathology                                           IA\                  EA\                  Adjusted p-value[^b^](#t002fn003){ref-type="table-fn"}
                                                                    n = 187              n = 307              
  ----------------------------------------------------------------- -------------------- -------------------- --------------------------------------------------------
  Malignant Yes, N (%)                                              187 (49.3%)          307 (47.2%)          0.99

  Size (cm)                                                                                                   

  Mean ± SD \[n\]\                                                  4.1 ± 2.1 \[185\]\   4.3 ± 2.5 \[307\]\   0.45
  (95% CI)                                                          (3.8, 4.4)           (4.0, 4.5)           

  Median (95% CI)                                                   4.0 (3.4, 4.0)       4.0 (4.0, 4.0)       

  Pathological Stage[^1^](#t002fn002){ref-type="table-fn"}, N (%)                                             

  Stage 0                                                           9 (4.8%)             10 (3.3%)            0.57

  Stage I                                                           36 (19.3%)           80 (26.1%)           

  Stage II                                                          63 (33.7%)           104 (33.9%)          

  Stage III                                                         69 (36.9%)           86 (28.0%)           

  Stage IV                                                          8 (4.3%)             25 (8.1%)            

  Unknown\*\*                                                       2 (1.1%)             2 (0.7%)             

  Tumor Location[^1^](#t002fn002){ref-type="table-fn"}, N (%)                                                 

  Cecum                                                             79 (42.2%)           131 (42.7%)          0.68

  Ascending Colon                                                   90 (48.1%)           127 (41.4%)          

  Hepatic Flexure                                                   7 (3.7%)             16 (5.2%)            

  Transverse Colon                                                  10 (5.3%)            28 (9.1%)            

  Unknown\*\*                                                       1 (0.5%)             5 (1.6%)             
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------

IA = Intracorporeal, EA = Extracorporeal, SD = standard deviation, cm = centimeter, CI = confidence interval n = number

^1^Combined other and unknown to one group called Unknown\*\*

^b^p value after propensity score adjustment

The IA group had a significantly lower conversion rate (p = 0.01), less estimated blood loss (p = 0.001), shorter time to first bowel movement (p = 0.01), and shorter hospital LOS (p = 0.02) than the EA group. There was only one (0.3%) conversion in the IA group and the reason was advanced cancer. The 19 (2.9%) conversions in the EA group were for intra-abdominal adhesions (n = 10), advanced cancer (n = 1), morbidly obese patients (n = 2), patient not suitable for minimally invasive approach (n = 1), bulky mass (n = 1), intraoperative bleeding (n = 1), disease characteristics (n = 2), and technical challenge of maintaining insufflation (n = 1). The OR time was significantly longer in the IA group (mean ±SD: 3.1 ± 0.9 hours) than in the EA group (mean ±SD: 2.5 ± 1.0 hours) (p\<0.0001) ([Table 3](#pone.0206277.t003){ref-type="table"}).

10.1371/journal.pone.0206277.t003

###### Procedure-related outcomes and overall complication rates.

![](pone.0206277.t003){#pone.0206277.t003g}

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variables                                                          IA\                   EA\                    Adjusted\
                                                                     n = 379\              n = 650\               p-value[^b^](#t003fn005){ref-type="table-fn"}
                                                                     (RRCIA n = 335\       (RRCEA n = 253\        
                                                                     LRCIA n = 44)         LRCEA n = 397)         
  ------------------------------------------------------------------ --------------------- ---------------------- -----------------------------------------------
  Conversion to open surgery, n (%)                                  1 (0.3%)              19 (2.9%)              0.01

  Estimated blood loss (ml), Mean +/-SD \[n\]                        58.9 ± 84.0 \[378\]   77.5 ± 102.8 \[638\]   0.001

  Transfusion, Yes, n (%)                                            4 (1.1%)              10 (1.5%)              0.42

  OR time (Wheels in/out) (hours), Mean +/-SD \[n\]                  3.1 ± 0.9 \[320\]     2.5 ± 1.0 \[574\]      \<0.0001

  Days to first bowel movement                                                                                    

      Mean ± SD \[n\]                                                2.7 ± 1.5 \[315\]     2.9 ± 1.5 \[571\]      0.01

      Median (95% CI)                                                3 (2, 3)              3 (3, 3)               

  Hospital LOS (days)                                                                                             

      Mean ± SD \[n\] (95% CI)                                       4.0 ± 2.8 \[379\]\    4.5 ± 3.4 \[649\]\     0.02
                                                                     (3.7, 4.3)            (4.2, 4.7)             

      Median (95% CI)                                                3 (3, 4)              4 (4, 4)               

  Intra-operative complications, n (%)                               2 (0.5%)              3 (0.5%)               0.99

  Post-operative complications prior to discharge, n (%)             57 (15.0%)            88 (13.5%)             0.55

  Post-operative complications hospital discharge to 30 days n (%)   18 (5.0%)             53 (8.9%)              0.04
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------

IA = Intracorporeal, EA = Extracorporeal

RRCIA = Robotic Right Colectomy Intracorporeal Anastomosis, LRCIA = Laparoscopic Right Colectomy Intracorporeal Anastomosis

RRCEA = Robotic Right Colectomy Extracorporeal Anastomosis, LRCEA = Laparoscopic Right Colectomy Extracorporeal Anastomosis

SD = standard deviation, min = minutes, ml = milliliters, n = number

^b^p value after propensity score adjustment

There was no significant difference in intraoperative complication rates (p = 0.99) and postoperative complication rates during the index hospitalization prior to discharge (p = 0.55) between the two groups. The overall complication rate from index hospitalization discharge up to 30 days after discharge was significantly lower in the intracorporeal anastomosis group than in the extracorporeal anastomosis group (5.0% vs. 8.9% respectively, p = 0.04) ([Table 3](#pone.0206277.t003){ref-type="table"}).

Specific complication rates were reported separately. *Clostridium* difficile colitis was slightly more prevalent in the extracorporeal group ([Table 4](#pone.0206277.t004){ref-type="table"}). Postoperative complication rates were similar between IA and EA groups with respect to cardiovascular, pulmonary, anesthetic, gastrointestinal, and genitourinary complications, surgical site infections, paralytic ileus, anastomotic leaks, and bleeding complications ([Table 4](#pone.0206277.t004){ref-type="table"}).

10.1371/journal.pone.0206277.t004

###### Complications during index hospitalization prior to discharge.

![](pone.0206277.t004){#pone.0206277.t004g}

  Postoperative Complications, prior to discharge, n %   IA          EA
  ------------------------------------------------------ ----------- -----------
  Cardiovascular Complications                           9 (2.4%)    11 (1.7%)
  Gastrointestinal Complications                         0 (0.0%)    6 (0.9%)
  Genitourinary Complications                            8 (2.1%)    13 (2.0%)
  Pulmonary Complications                                10 (2.6%)   11 (1.7%)
  Anesthetic Complications                               2 (0.5%)    1 (0.2%)
  Post-operative Bleeding                                16 (4.2%)   29 (4.5%)
  Surgical Site Infection                                2 (0.5%)    9 (1.4%)
  Anastomotic Leakage                                    0 (0.0%)    6 (0.9%)
  Paralytic Ileus                                        9 (2.4%)    19 (2.9%)
  Small Bowel Obstruction                                1 (0.3%)    5 (0.8%)
  *Clostridium* difficile Colitis                        0 (0.0%)    6 (0.9%)

IA = Intracorporeal, EA = Extracorporeal

RRCIA = Robotic Right Colectomy Intracorporeal Anastomosis, LRCIA = Laparoscopic Right Colectomy Intracorporeal Anastomosis

RRCEA = Robotic Right Colectomy Extracorporeal Anastomosis, LRCEA = Laparoscopic Right Colectomy Extracorporeal Anastomosis

Gastrointestinal complications and surgical site infections following discharge up to 30-days were also higher in the extracorporeal group than the intracorporeal anastomosis group ([Table 5](#pone.0206277.t005){ref-type="table"}).

10.1371/journal.pone.0206277.t005

###### Complications from discharge up to 30 days.
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  Postoperative Complications from Discharge to 30 Days   IA         EA
  ------------------------------------------------------- ---------- -----------
  Cardiovascular Complications                            0 (0.0%)   0 (0.0%)
  Gastrointestinal Complications                          2 (0.6%)   10 (1.7%)
  Genitourinary Complications                             1 (0.3%)   4 (0.7%)
  Pulmonary Complications                                 0 (0.0%)   3 (0.5%)
  Post-operative Bleeding                                 4 (1.1%)   6 (1.0%)
  Surgical Site Infection                                 5 (1.4%)   16 (2.7%)
  Other Wound Complications                               0 (0.0%)   2 (0.3%)
  Paralytic Ileus                                         2 (0.6%)   5 (0.8%)
  Small Bowel Obstruction                                 0 (0.0%)   2 (0.3%)
  Bowel Obstruction                                       0 (0.0%)   1 (0.2%)
  C. difficile Colitis                                    1 (0.3%)   1 (0.2%)
  Other                                                   3 (0.8%)   2 (0.3%)

IA = Intracorporeal, EA = Extracorporeal, SD = standard deviation, min = minutes, n = number

RRCIA = Robotic Right Colectomy Intracorporeal Anastomosis, LRCIA = Laparoscopic Right Colectomy Intracorporeal Anastomosis

RRCEA = Robotic Right Colectomy Extracorporeal Anastomosis, LRCEA = Laparoscopic Right Colectomy Extracorporeal Anastomosis

This multi-institutional retrospective propensity score-matched analysis of minimally invasive laparoscopic and robotic-assisted right colectomies demonstrates that the intracorporeal anastomosis is associated with fewer conversions to open, shorter hospital LOS, and fewer overall complications after discharge when compared to minimally invasive laparoscopic and robotic-assisted right colectomies with an extracorporeal anastomosis. Though estimated blood loss and time to gastrointestinal recovery were statistically different, these differences were small and unlikely to be significantly different in the clinical setting. The number of individual postoperative complications prior to and after discharge were quite small ([Table 4](#pone.0206277.t004){ref-type="table"} and [Table 5](#pone.0206277.t005){ref-type="table"}). Therefore, no statistical comparisons were provided for individual postoperative complications as definitive conclusions would be difficult to determine.

Minimally invasive studies comparing intra- and extracorporeal anastomosis {#sec015}
--------------------------------------------------------------------------

Other studies including two meta-analyses also revealed short-term outcomes advantages with the laparoscopic IA approach, with some showing significantly shorter intestinal recovery time, less analgesic requirements, shorter hospital LOS, and less short-term morbidity when compared to the EA group.\[[@pone.0206277.ref014], [@pone.0206277.ref016]\] These authors suggest that the paucity of literature prior to these meta-analyses comparing IA and EA anastomoses was due to the technical challenges of laparoscopic stapling and suturing.\[[@pone.0206277.ref022], [@pone.0206277.ref025], [@pone.0206277.ref027]--[@pone.0206277.ref029]\]

Robotic-assisted studies to date have also shown short-term outcomes advantages to the IA approach including intestinal recovery time and hospital LOS.\[[@pone.0206277.ref015], [@pone.0206277.ref017]\] Previous robotic-assisted reports were comparisons of the robotic-assisted IA approach with the laparoscopic EA approach. These studies showed that the robotic-assisted intracorporeal group had significantly shorter hospital LOS than the laparoscopic extracorporeal group but there was no difference when compared to the laparoscopic intracorporeal group.\[[@pone.0206277.ref017]\] One study showed fewer anastomotic complications and incisional hernias in the robotic-assisted intracorporeal group when compared to the laparoscopic extracorporeal group.\[[@pone.0206277.ref015]\] Another study concluded that the intracorporeal anastomosis may facilitate extraction of longer specimens with less trauma through smaller incisions.\[[@pone.0206277.ref030]\] Other laparoscopic right colectomy studies have confirmed shorter incisions and better cosmetic results for the intracorporeal approach.\[[@pone.0206277.ref022], [@pone.0206277.ref024], [@pone.0206277.ref025], [@pone.0206277.ref028]\] Our study differs from prior published studies in that we performed a multi-center analysis with a larger sample size with results that may be more generalizable.

Specific outcomes {#sec016}
-----------------

### Conversion and operative time {#sec017}

Our study revealed significantly fewer conversions and longer operating time for the IA group. Other studies reveal conflicting results with some showing significantly fewer conversions for the MIS intracorporeal approach when compared to the extracorporeal approach and others that show no significant difference.\[[@pone.0206277.ref021], [@pone.0206277.ref025], [@pone.0206277.ref031]\] Future studies that include subgroup analysis may suggest that patients with higher BMI may have fewer conversions if selected for the intracorporeal technique. Operative times are also inconclusive with some reports showing longer times for the IA approach and others showing no difference or shorter times when compared to EA.\[[@pone.0206277.ref022], [@pone.0206277.ref024], [@pone.0206277.ref025], [@pone.0206277.ref028], [@pone.0206277.ref031]\] Operative times may improve with experience and upon completion of the surgeon learning curve.\[[@pone.0206277.ref032], [@pone.0206277.ref033]\]

### Intestinal recovery {#sec018}

Others have confirmed the outcomes advantages of the intracorporeal option for MIS right colectomy with respect to gastrointestinal recovery time.\[[@pone.0206277.ref015]--[@pone.0206277.ref017], [@pone.0206277.ref021]--[@pone.0206277.ref025]\] The entire operation including ileocolic mobilization, vessel ligation, takedown of the mesentery, division of the ileum and transverse colon, and anastomosis is done entirely prior to specimen extraction. With the intracorporeal anastomosis, there is no need to perform one of the most important parts of the operation through a small incision with poor visualization and there is no unintentional twisting or mesenteric stretching that can result in edema, bleeding, and resultant delayed intestinal recovery. The extracorporeal technique often requires more mobilization of a transverse colon that may not easily reach an extracorporeal extraction site incision.\[[@pone.0206277.ref014], [@pone.0206277.ref015], [@pone.0206277.ref017], [@pone.0206277.ref034]--[@pone.0206277.ref037]\] For some patients with high BMI, short/thick mesentery, and thick abdominal wall, the only minimally invasive option may be an intracorporeal anastomosis with less dissection of tissues that remain in situ and without the risk of mesenteric injury and need to lengthen the extraction site incision.\[[@pone.0206277.ref022]\] The advantages of the intracorporeal approach are for those capable of mastering minimally invasive suturing techniques. The robotic-assisted platform may be more suited for many surgeon skill sets due to the vision, articulating instruments, and other ergonomic advantages.\[[@pone.0206277.ref022], [@pone.0206277.ref031]\]

### Hospital LOS {#sec019}

Several studies demonstrate an advantage for the intracorporeal anastomosis for hospital LOS while others show no significant difference between groups.\[[@pone.0206277.ref014]--[@pone.0206277.ref017], [@pone.0206277.ref021]--[@pone.0206277.ref025], [@pone.0206277.ref027], [@pone.0206277.ref028], [@pone.0206277.ref030], [@pone.0206277.ref031]\] This outcome is related to intestinal recovery time but there are other potentially confounding factors that contribute. We were unable to control for programs implementing Enhanced Recovery Pathways of varying degrees of standardization that decrease hospital LOS.\[[@pone.0206277.ref038], [@pone.0206277.ref039]\]

### Postoperative complications {#sec020}

Most studies show no difference in postoperative complications between intra- and extracorporeal right colectomy groups. Our study showed a significant difference in postoperative complications after discharge up to 30-days. This significant difference was not apparent with respect to a specific complication but rather a cumulative effect of all postoperative complications. The difference in complications between groups has several possible explanations--extraction site difficulties in the extracorporeal group may be one. Though IA vs EA decision making was characterized by the method employed by the surgeon at the time of the study, it is possible that IA serves as a proxy for surgeons further along in their learning curve.

### Incisional hernia and incision size {#sec021}

The right colectomy extraction site for the extracorporeal approach is typically the midline where the incisional hernia rate is highest.\[[@pone.0206277.ref016], [@pone.0206277.ref018]--[@pone.0206277.ref020]\] Several studies have shown that the MIS intracorporeal anastomosis allows specimen extraction at off-midline sites and the Pfannenstiel location with decreased risk for subsequent incisional hernias.\[[@pone.0206277.ref016], [@pone.0206277.ref018]--[@pone.0206277.ref020]\] Our multicenter retrospective study design made it difficult to obtain incisional length and hernia metrics and so we did not include these data points. Recognizing this limitation, this study serves as a reference for a prospective study that is currently underway with a focus on comparing incisional hernia rates for intracorporeal and extracorporeal techniques.

This study has inherent limitations of any retrospective study with respect to dissimilar comparison groups. There was no way to control for regional differences in multicenter patient populations, surgeon variations in techniques, and surgical decision-making when choosing an intracorporeal or extracorporeal anastomosis. To address this potential limitation, surgeons contributed patients to the group that defined the technique they were using at the time of the study. That is, surgeons did not choose one technique over the other based on operative degree of difficulty. We could not control for the degree of intracorporeal dissection prior to extracorporeal extraction. It is possible that more limited intracorporeal mobilization and dissection prior to extracorporeal extraction could negatively impact results for this group. This is also a potential strength of the study, however, recognizing that this comparison is not just about the anastomosis but a comparison of all segments of the operation including mobilization techniques, likely less standardized with respect to the extracorporeal approach. Though time to first bowel movement was significantly different in this study, the difference was small (2.7 ± 1.5 days vs 2.9 ± 1.5 days) and is likely not clinically significant. There may have been other unmeasured differences in techniques between clinical sites that could potentially impact results.

We used propensity matching to account for selection bias but even this method may not account for all potential confounders. However, in the absence of well-designed prospective comparative studies, propensity score matching from real world electronic medical record data provides a surrogate model to adjust for patient population heterogeneity. Some important variables like incisional hernias, incision size, and the concurrent implementation of Enhanced Recovery Pathways were not able to be collected for this study and will be the subject of our prospective study. Nevertheless, this study is unique in that it brings together both MIS options in both study groups for comparison and provides generalizable data.

The traditional open approach to right colectomy is still common with MIS techniques adopted in only 50--60% of cases.\[[@pone.0206277.ref009]--[@pone.0206277.ref013]\] There is a need to increase MIS training efforts and options. The intracorporeal anastomosis is an advantage for both MIS approaches.\[[@pone.0206277.ref022], [@pone.0206277.ref024], [@pone.0206277.ref025], [@pone.0206277.ref028], [@pone.0206277.ref031]\] Operative times may improve with experience and upon completion of the learning curve.\[[@pone.0206277.ref022], [@pone.0206277.ref024], [@pone.0206277.ref025], [@pone.0206277.ref028], [@pone.0206277.ref031]--[@pone.0206277.ref033]\] This study that presents laparoscopic and robotic-assisted data together in both study arms may help guide MIS choices for open and extracorporeal surgeons who recognize the value of the intracorporeal anastomosis.

Conclusions {#sec022}
===========

This multi-institutional propensity score comparison of minimally invasive laparoscopic and robotic-assisted intracorporeal and extracorporeal anastomosis after right colectomy demonstrates several short-term outcomes advantages for the intracorporeal approach. These data may guide surgeons focused on upgrading minimally invasive training efforts and those choosing minimally invasive options for colectomies.
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